The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, TG Therapeutics Inc’s stock clocked out at $33.37, down -0.24% from its previous closing price of $33.45. In other words, the price has decreased by -$0.24 from its previous closing price. On the day, 2.09 million shares were traded. TGTX stock price reached its highest trading level at $34.04 during the session, while it also had its lowest trading level at $33.05.
Ratios:
To gain a deeper understanding of TGTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.91 and its Current Ratio is at 4.59. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.
On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 03 ’25 when Power Sean A sold 11,337 shares for $30.29 per share. The transaction valued at 343,443 led to the insider holds 670,632 shares of the business.
Power Sean A sold 10,021 shares of TGTX for $285,939 on Jan 06 ’25. The CFO now owns 660,611 shares after completing the transaction at $28.53 per share. On Jan 06 ’25, another insider, Power Sean A, who serves as the Officer of the company, bought 10,021 shares for $28.53 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 5194540544 and an Enterprise Value of 4702515200. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.62 while its Price-to-Book (P/B) ratio in mrq is 27.05. Its current Enterprise Value per Revenue stands at 17.759 whereas that against EBITDA is -11525.773.
Stock Price History:
The Beta on a monthly basis for TGTX is 2.27, which has changed by 0.9768957 over the last 52 weeks, in comparison to a change of 0.23095727 over the same period for the S&P500. Over the past 52 weeks, TGTX has reached a high of $36.84, while it has fallen to a 52-week low of $12.84. The 50-Day Moving Average of the stock is 5.48%, while the 200-Day Moving Average is calculated to be 43.63%.
Shares Statistics:
It appears that TGTX traded 3.03M shares on average per day over the past three months and 2286610 shares per day over the past ten days. A total of 155.78M shares are outstanding, with a floating share count of 140.52M. Insiders hold about 9.73% of the company’s shares, while institutions hold 65.77% stake in the company. Shares short for TGTX as of 1736899200 were 27632271 with a Short Ratio of 9.11, compared to 1734048000 on 27139751. Therefore, it implies a Short% of Shares Outstanding of 27632271 and a Short% of Float of 19.610001.
